Raleigh A. Bowden

15.7k total citations · 5 hit papers
98 papers, 11.4k citations indexed

About

Raleigh A. Bowden is a scholar working on Epidemiology, Infectious Diseases and Hematology. According to data from OpenAlex, Raleigh A. Bowden has authored 98 papers receiving a total of 11.4k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Epidemiology, 39 papers in Infectious Diseases and 27 papers in Hematology. Recurrent topics in Raleigh A. Bowden's work include Cytomegalovirus and herpesvirus research (41 papers), Antifungal resistance and susceptibility (26 papers) and Hematopoietic Stem Cell Transplantation (23 papers). Raleigh A. Bowden is often cited by papers focused on Cytomegalovirus and herpesvirus research (41 papers), Antifungal resistance and susceptibility (26 papers) and Hematopoietic Stem Cell Transplantation (23 papers). Raleigh A. Bowden collaborates with scholars based in United States, South Africa and United Kingdom. Raleigh A. Bowden's co-authors include Kieren A. Marr, Theodore C. White, Michael Boeckh, David Myerson, Joel D. Meyers, Lawrence Corey, Wendy M. Leisenring, J.-A. van Burik, Monica A. Slavin and Kristy Seidel and has published in prestigious journals such as New England Journal of Medicine, Blood and Annals of Internal Medicine.

In The Last Decade

Raleigh A. Bowden

98 papers receiving 11.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance

1998 1.1k citations Theodore C. White, Kieren A. Marr et al. profile →
Efficacy and Safety of Fluconazole Prophylaxis for Fungal Infections after Marrow Transplantation--A Prospective, Randomized, Double-Blind Study

1995 611 citations Monica A. Slavin, Joel D. Meyers et al. The Journal of Infectious Diseases profile →
Epidemiology ofAspergillusInfections in a Large Cohort of Patients Undergoing Bone Marrow Transplantation

1997 563 citations Raleigh A. Bowden et al. The Journal of Infectious Diseases profile →
Treatment of Cytomegalovirus Pneumonia with Ganciclovir and Intravenous Cytomegalovirus Immunoglobulin in Patients with Bone Marrow Transplants

1988 412 citations Raleigh A. Bowden et al. profile →
Cytomegalovirus Immune Globulin and Seronegative Blood Products to Prevent Primary Cytomegalovirus Infection after Marrow Transplantation

1986 381 citations Raleigh A. Bowden, E. Donnall Thomas et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Raleigh A. Bowden

Since Specialization

Citations

This map shows the geographic impact of Raleigh A. Bowden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raleigh A. Bowden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raleigh A. Bowden more than expected).

Fields of papers citing papers by Raleigh A. Bowden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raleigh A. Bowden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raleigh A. Bowden. The network helps show where Raleigh A. Bowden may publish in the future.

Co-authorship network of co-authors of Raleigh A. Bowden

This figure shows the co-authorship network connecting the top 25 collaborators of Raleigh A. Bowden. A scholar is included among the top collaborators of Raleigh A. Bowden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raleigh A. Bowden. Raleigh A. Bowden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors 2002 ·Transfusion ·Kai Hübel, Rachel A. Carter, W. Conrad Liles, David C. Dale, Thomas H. Price, Raleigh A. Bowden, Scott D. Rowley, Thomas R. Chauncey, William Bensinger, Michael Boeckh	89
2	Treatment of 21 Cases of Invasive Mucormycosis with Amphotericin B Colloidal Dispersion 2001 ·European Journal of Clinical Microbiology & Infectious Diseases ·Raoul Herbrecht, V. Letscher‐Bru, Raleigh A. Bowden, Shimon Kusne, E. Anaissie, John R. Graybill, Gary A. Noskin, B. Oppenheim, Emmanuel Andrès, Larry Pietrelli	101
3	Candidemia in Allogeneic Blood and Marrow Transplant Recipients: Evolution of Risk Factors after the Adoption of Prophylactic Fluconazole 2000 ·The Journal of Infectious Diseases ·Kieren A. Marr, Kristy Seidel, Theodore C. White, Raleigh A. Bowden	366
4	Human Herpesvirus 6 Infections after Bone Marrow Transplantation: Clinical and Virologic Manifestations 1999 ·The Journal of Infectious Diseases ·Richard W. Cone, Meei‐Li Huang, Lawrence Corey, Judith E. Zeh, Rhoda L. Ashley, Raleigh A. Bowden	105
5	The Population Pharmacokinetics of Amphotericin B Colloidal Dispersion in Patients Receiving Bone Marrow Transplants 1999 ·Chemotherapy ·Michael Amantea, Raleigh A. Bowden, Alan Forrest, Peter K. Working, Mary S. Newman, Richard D. Mamelok	7
6	The impact of candidemia on length of stay, outcomes, and overall cost of illness 1998 ·Clinical Infectious Diseases ·(unknown), Michael T. Halpern, Raleigh A. Bowden	1
7	Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis. 1997 ·PubMed ·Mary H. White, E. Anaissie, Shimon Kusne, John R. Wingard, J. Hiemenz, Alan Cantor, Marc Gurwith, Charles Du Mond, Richard D. Mamelok, Raleigh A. Bowden	133
8	PLASMA POLYMERASE CHAIN REACTION FOR CYTOMEGALOVIRUS DNA AFTER ALLOGENEIC MARROW TRANSPLANTATION 1997 ·Transplantation ·Michael Boeckh, Ghislaine Gallez‐Hawkins, David Myerson, John A. Zaia, Raleigh A. Bowden	114
9	Summary of the international consensus symposium on advances in the diagnosis, treatment and prophylaxis of cytomegalovirus infection 1996 ·Antiviral Research ·Jan T. M. van der Meer, W. Lawrence Drew, Raleigh A. Bowden, George J. Galasso, Paul Griffiths, (unknown), Christine Katlama, Stephen A. Spector, Richard J. Whitley	73
10	Hepatic Mucormycosis in a Bone Marrow Transplant Recipient Who Ingested Naturopathic Medicine 1996 ·Clinical Infectious Diseases ·(unknown), Wesley C. Van Voorhis, Michael Boeckh, D Mattson, Raleigh A. Bowden	106
11	Cytomegalovirus Infection in Marrow Transplantation 1995 ·Cancer treatment and research ·Michael Boeckh, Raleigh A. Bowden	19
12	PREDICTION OF CYTOMEGALOVIRUS PNEUMONIA AFTER MARROW TRANSPLANTATION FROM CELLULAR CHARACTERISTICS AND CYTOMEGALOVIRUS CULTURE OF BRONCHOALVEOLAR LAVAGE FLUID 1994 ·Transplantation ·Monica A. Slavin, Ted Gooley, Raleigh A. Bowden	15
13	Etiology and outcome of diarrhea after marrow transplantation: A prospective study 1994 ·Gastroenterology ·(unknown), Suzanne M. Matsui, Roger S. Lo, (unknown), Raleigh A. Bowden, Robert C. Hackman, (unknown), Motomi Mori, Phillip I. Tarr, Lyndon S. Oshiro, Juan E. Ludert, Joel D. Meyers, George B. McDonald	193
14	MONONUCLEAR CELL RECONSTITUTION IN THE LUNG AFTER MARROW TRANSPLANTATION LACK OF INFLUENCE OF CYTOMEGALOVIRUS PNEUMONIA, IRRADIATION, AND GRAFT-VERSUS-HOST DISEASE 1993 ·Transplantation ·Raleigh A. Bowden, Motomi Mori, (unknown), Robert C. Hackman, Kenneth J. Kopecky, Stephen W. Crawford	12
15	Cytomegalovirus-Induced Hemorrhagic Cystitis Following Bone Marrow Transplantation 1993 ·Clinical Infectious Diseases ·D H Spach, Jorgen Bauwens, David Myerson, M. M. Mustafa, Raleigh A. Bowden	37
16	Cytomegalovirus (CMV)-Specific Intravenous Immunoglobulin for the Prevention of Primary CMV Infection and Disease after Marrow Transplant 1991 ·The Journal of Infectious Diseases ·Raleigh A. Bowden, L Fisher, Kenneth A. Rogers, (unknown), Joel D. Meyers	81
17	Anal Human Papillomavirus Infection among Human Immunodeficiency Virus-Seropositive and -Seronegative Men 1990 ·The Journal of Infectious Diseases ·Nancy B. Kiviat, Anne Rompalo, Raleigh A. Bowden, Denise A. Galloway, K. K. Holmes, Lawrence Corey, Pacita L. Roberts, W. E. Stamm	77
18	Immunomodulatory and Antimicrobial Efficacy of Intravenous Immunoglobulin in Bone Marrow Transplantation 1990 ·New England Journal of Medicine ·Keith M. Sullivan, Kenneth J. Kopecky, (unknown), L Fisher, CD Buckner, Joel D. Meyers, George W. Counts, Raleigh A. Bowden, Finn Bo Petersen, Robert P. Witherspoon, Miriam D. Budinger, Richard S. Schwartz, Frederick R. Appelbaum, Reginald A. Clift, John A. Hansen, Jean E. Sanders, E. Donnall Thomas, Rainer Storb	286
19	Increased Cytotoxicity Against Cytomegalovirus-Infected Target Cells by Bronchoalveolar Lavage Cells from Bone Marrow Transplant Recipients with Cytomegalovirus Pneumonia 1988 ·The Journal of Infectious Diseases ·Raleigh A. Bowden, (unknown), Kenneth J. Kopecky, Stephen W. Crawford, Joel D. Meyers	11
20	An erysipelas-like scalp cellulitis due to Haemophilus influenzae type b 1980 ·The Journal of Pediatrics ·Ronald J. Sokol, Raleigh A. Bowden	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact